steady as she goes
The Company remains in dialogue with a number of pharmaceutical companies, which could lead to multiple
international licensing opportunities. Vectus continues to receive enquiries from industry participants who
recognise the significant potential of the Company’s novel anti-fibrotic compounds.
this was the most interesting statement for me...
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report & Appendix 4C
steady as she goesThe Company remains in dialogue with a number...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VBS (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.1¢ |
Change
0.001(1.25%) |
Mkt cap ! $4.313M |
Open | High | Low | Value | Volume |
8.1¢ | 8.1¢ | 8.1¢ | $567 | 7K |
Featured News
VBS (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online